DESIGN THERAPEUTICS INC's ticker is DSGN and the CUSIP is 25056L103. A total of 98 filers reported holding DESIGN THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 3.50 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $12,701 | +9.2% | 2,016 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $11,632 | -49.6% | 2,016 | -10.4% | 0.00% | 0.0% |
| Q4 2022 | $23,075 | -31.9% | 2,249 | +11.0% | 0.00% | -50.0% |
| Q3 2022 | $33,891 | +19.4% | 2,027 | 0.0% | 0.00% | +100.0% |
| Q2 2022 | $28,378 | -13.3% | 2,027 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $32,736 | -81.0% | 2,027 | -74.8% | 0.00% | -50.0% |
| Q4 2021 | $172,308 | – | 8,048 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 5,364,850 | $78,810,000 | 3.20% |
| Logos Global Management LP | 2,772,501 | $40,728,000 | 2.94% |
| EcoR1 Capital, LLC | 1,863,098 | $27,369,000 | 0.95% |
| RA Capital Management | 2,186,636 | $32,122,000 | 0.44% |
| Vivo Capital, LLC | 530,991 | $7,800,000 | 0.35% |
| Avoro Capital Advisors LLC | 1,468,318 | $21,570,000 | 0.34% |
| Artal Group S.A. | 400,000 | $5,876,000 | 0.13% |
| Rock Springs Capital Management LP | 334,050 | $4,907,000 | 0.10% |
| Baker Brothers Advisors | 1,436,636 | $21,104,000 | 0.09% |
| Eventide Asset Management | 400,000 | $5,876,000 | 0.08% |